VRS
GYRE icon

Virginia Retirement Systems’s Gyre Therapeutics GYRE Stock Holding History

Virginia Retirement Systems’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-33
Closed -$116K – 971
2014
Q2 		$116K Sell
33
-9
-21% -$29.4K ﹤0.01% 946
2014
Q1 		$159K Hold
42
– – ﹤0.01% 931
2013
Q4 		$139K Sell
42
-1
-2% -$3.94K ﹤0.01% 850
2013
Q3 		$181K Hold
43
– – ﹤0.01% 792
2013
Q2 		$145K Buy
+43
New +$164K ﹤0.01% 945

Other funds holding GYRE

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Virginia Retirement Systems's GYRE Position: Q3 2014 in Review

Virginia Retirement Systems sold out of Gyre Therapeutics (GYRE) in Q3 2014, closing a stake of 33 shares — an estimated $116K sold.

Virginia Retirement Systems first reported a position in GYRE in Q2 2013 and held it in 5 quarters. The position peaked at $181K in Q3 2013. 55 funds tracked by Wall St. Rank hold GYRE as of Q3 2014.

  • Virginia Retirement Systems reported no remaining Gyre Therapeutics position as of Q3 2014 after selling out during the quarter.
  • Virginia Retirement Systems sold 33 Gyre Therapeutics shares in Q3 2014, an estimated $116K.
  • Virginia Retirement Systems first reported a position in Gyre Therapeutics in Q2 2013 and held it in 5 quarters.
  • Virginia Retirement Systems's Gyre Therapeutics position peaked at $181K in Q3 2013.
  • 55 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q3 2014.

Based on Virginia Retirement Systems's 13F filing for Q3 2014, filed 31 Oct 2014.